Latest Share Chat

Astrazeneca Share News (AZN)

Astrazeneca Information

Buy AZN Shares
Add AZN to Watchlist
Add AZN to Alert

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 12,122.00

Bid: 12,118.00

Ask: 12,122.00

Change: -34.00 (-0.28%)

Spread: 4.00 (0.033%)

Open: 12,092.00

High: 12,178.00

Low: 12,010.00

Prev. Close: 12,156.00

Last checked at -

BROKER RATINGS SUMMARY: Cantor Upgrades easyJet To Buy From Hold

Tue, 09th Aug 2016 08:33

LONDON (Alliance News) - The following shares received analyst recommendations Tuesday morning and Monday:
----------
FTSE 100
----------
CANTOR FITZGERALD RAISES EASYJET TO 'BUY' ('HOLD') - TARGET 1300 PENCE
----------
TRADERS: MACQUARIE CUTS AVIVA TO 'NEUTRAL' ('OUTPERFORM')
----------
GOLDMAN CUTS AVIVA PRICE TARGET TO 480 (485) PENCE - 'BUY'
----------
BERENBERG RAISES RSA INSURANCE PRICE TARGET TO 501 (448) PENCE - 'HOLD'
----------
CITIGROUP REVISES STANDARD CHARTERED PRICE TARGET TO 750 PENCE - 'BUY'
----------
GOLDMAN RAISES STANDARD CHARTERED PRICE TARGET TO 760 (740) PENCE - 'BUY'
----------
CITIGROUP RAISES HSBC PRICE TARGET TO 600 (515) PENCE - 'BUY'
----------
GOLDMAN RAISES RBS PRICE TARGET TO 240 (235) PENCE - 'BUY'
----------
GOLDMAN CUTS LLOYDS PRICE TARGET TO 53 (55) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES BARCLAYS PRICE TARGET TO 175 (170) PENCE - 'NEUTRAL'
----------
TRADERS: NUMIS CUTS INFORMA TO 'ADD' ('BUY')
----------
RBC RAISES ANTOFAGASTA PRICE TARGET TO 500 (410) PENCE - 'SECTOR PERFORM'
----------
DEUTSCHE BANK RAISES BUNZL PRICE TARGET TO 2520 (2100) PENCE - 'BUY'
----------
JPMORGAN RAISES ASTRAZENECA PRICE TARGET TO 4900 (4800) PENCE - 'NEUTRAL'
----------
CREDIT SUISSE RAISES RELX PRICE TARGET TO 1370 (1210) PENCE - 'NEUTRAL'
----------
FTSE 250
----------
LIBERUM CUTS SERCO GROUP TO 'HOLD' ('BUY') - TARGET 135 (120) PENCE
----------
RBC RAISES INDIVIOR PRICE TARGET TO 325 (185) PENCE - 'SECTOR PERFORM'
----------
GOLDMAN RAISES WILLIAM HILL PRICE TARGET TO 320 (310) PENCE - 'NEUTRAL'
----------
DEUTSCHE BANK CUTS WILLIAM HILL PRICE TARGET TO 390 (420) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES LADBROKES PRICE TARGET TO 148 (136) PENCE - 'HOLD'
----------
SHORE CAPITAL RAISES OCADO TO 'HOLD' ('SELL')
----------
JPMORGAN CUTS JLT GROUP PRICE TARGET TO 850 (1020) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES MEGGITT PRICE TARGET TO 445 (395) PENCE - 'NEUTRAL'
----------
CITIGROUP RAISES JD WETHERSPOON PRICE TARGET TO 980 (840) PENCE - 'BUY'
----------
CREDIT SUISSE RAISES RENTOKIL INITIAL PT TO 235 (225) PENCE - 'OUTPERFORM'
----------
TRADERS: MACQUARIE RAISES PARAGON GROUP TO 'OUTPERFORM' ('NEUTRAL')
----------
GOLDMAN RAISES VEDANTA RESOURCES PRICE TARGET TO 440 (425) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES METRO BANK PRICE TARGET TO 1630 (1560) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES BBA AVIATION PRICE TARGET TO 285 (186) PENCE - 'NEUTRAL'
----------
MAIN MARKET AND AIM
----------
LIBERUM RAISES BOOHOO PRICE TARGET TO 90 (80) PENCE - 'BUY'
----------
TRADERS: NUMIS RAISES SDL TO 'ADD' ('HOLD')
----------
TRADERS: NUMIS RAISES DEVRO TO 'BUY' ('ADD')
----------
BERENBERG CUTS MOTHERCARE PRICE TARGET TO 100 (130) PENCE - 'SELL'
----------
BERENBERG CUTS CARPETRIGHT PRICE TARGET TO 230 (450) PENCE - 'HOLD'
----------
BERENBERG CUTS TOPPS TILES PRICE TARGET TO 125 (155) PENCE - 'HOLD'
----------
PANMURE RAISES GEMFIELDS RESOURCES PRICE TARGET TO 61 (57) PENCE - 'BUY'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News

Today 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Today 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Today 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

Latest Share Chat

Astrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Cantor Upgrades easyJet To Buy From Hold

Login to your account

Quickpicks are a member only feature

Login to your account